Abstract
The article seeks to analyze the different hormonal and alternative treatments that aim to mitigate vasomotor events and their relationship with the improvement in the quality of life of climacteric women. The climacteric is defined as the transition period between the woman's reproductive and non-reproductive phase, marked by the decrease in estrogen secretion. The hormonal imbalances that occur during this period are responsible for the manifestations that impair the woman's quality of life, such as vasomotor symptoms, among them hot flushes and sweating, these being the most common phenomena in the diagnosis of climacteric. During this transition period, about 25% of women will need therapy for symptom relief. Treatment during this phase should be individualized for each specific case, always evaluating the characteristics presented by each patient, and can vary between Hormone Replacement Therapy (HRT), non-hormonal and non-pharmacological treatment. The HRT used to control climacteric phenomena has variation in results according to the drug use scheme and prolonged use is not advised, due to the appearance of adverse reactions, such as venous thrombosis.